Research ArticleOriginal Research

Hypoxemia Adds to the CURB-65 Pneumonia Severity Score in Hospitalized Patients With Mild Pneumonia

Francisco Sanz, Marcos I Restrepo, Estrella Fernández, Eric M Mortensen, María Carmen Aguar, Ángela Cervera, Eusebi Chiner, Jose Blanquer and the Neumonía Adquirida en la Comunidad de la Comunidad Valenciana Study Group
Respiratory Care May 2011, 56 (5) 612-618; DOI: https://doi.org/10.4187/respcare.00853

References

  1. 1.↵
    World Health Organization/WHO Statistical Information System (WHOSIS). WHO Mortality Database, 2005. http://www.who.int/healthinfo/morttables/en/index.html. Accessed March 9, 2011.
  2. 2.
    1. Armstrong GL,
    2. Conn LA,
    3. Pinner RW
    . Trends in infectious disease mortality in the United States during the 20th century. JAMA 1999;281(1):61–66.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Feikin DR,
    2. Schuchat A,
    3. Kolczak M,
    4. Barrett NL,
    5. Harrison LH,
    6. Lefkowitz L,
    7. et al
    . Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000;90(2):223–229.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Macfarlane JT,
    2. Boswell T,
    3. Douglas G,
    4. Finch R,
    5. Holmes W,
    6. Honeybourne D,
    7. et al
    . BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001;56(Suppl 4):iv1–iv64.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Macfarlane JT,
    2. Boldy D
    . 2004 update of BTS pneumonia guidelines: what's new? Thorax 2004;59(5):364–366.
    OpenUrlFREE Full Text
  6. 6.↵
    1. Mandell LA,
    2. Wunderink RG,
    3. Anzueto A,
    4. Bartlett JG,
    5. Campbell GD,
    6. Dean NC,
    7. et al
    . Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27–S72.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Ewig S,
    2. Welte T
    . CRB-65 for the assessment of pneumonia severity: who could ask for more? (editorial). Thorax 2008;63(8):665–666.
    OpenUrlFREE Full Text
  8. 8.↵
    1. Fine MJ,
    2. Auble TE,
    3. Yealy DM,
    4. Hanusa BH,
    5. Weissfeld LA,
    6. Singer DE,
    7. et al
    . A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336(4):243–250.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Lim WS,
    2. Lewis S,
    3. Macfarlane JT
    . Severity prediction rules in community-acquired pneumonia: a validation study. Thorax 2000;55(3):219–223.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Lim WS,
    2. van der Eerden MM,
    3. Laing R,
    4. Boersma WG,
    5. Karalus N,
    6. Town GI,
    7. et al
    . Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58(5):377–382.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Man SY,
    2. Lee N,
    3. Ip M,
    4. Antonio GE,
    5. Chau SS,
    6. Mak P,
    7. Graham CA,
    8. et al
    . Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 2007;62(4):348–353.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Rosón B,
    2. Carratalà J,
    3. Dorca J,
    4. Casanova A,
    5. Manresa F,
    6. Gudiol F
    . Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 2001;33(2):158–165.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Rabe KF,
    2. Hurd S,
    3. Anzueto A,
    4. Barnes PJ,
    5. Buist SA,
    6. Calverley P,
    7. et al
    ; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532–555.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Bowton DL,
    2. Scuderi PE,
    3. Haponik EF
    . The incidence and effect on outcome of hypoxemia in hospitalized medical patients. Am J Med 1994(1):97:38–46.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Karbing DS,
    2. Kjaergaard S,
    3. Smith BW,
    4. Espersen K,
    5. Allerød C,
    6. Andreassen S,
    7. et al
    . Variation in the PaO2/FIO2 ratio with FIO2: mathematical and experimental description, and clinical relevance. Crit Care 2007;11(6):R118.
  16. 16.↵
    1. Ferrer M,
    2. Esquinas A,
    3. Leon M,
    4. Gonzalez G,
    5. Alarcon A,
    6. Torres A
    . Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med 2003;168(12):1438–1444.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Mortensen EM,
    2. Coley CM,
    3. Singer DE,
    4. Marrie TJ,
    5. Obrosky DS,
    6. Kapoor WN,
    7. Fine MJ
    . Causes of death for patients with community-acquired pneumonia. Arch Intern Med 2002;162(9):1059–1064.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Myint PK,
    2. Kamath AV,
    3. Vowler SL,
    4. Maisey DN,
    5. Harrison BD
    . Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing 2006;35(3):286–291.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. España PP,
    2. Capelastegui A,
    3. Gorordo I,
    4. Esteban C,
    5. Oribe M,
    6. Ortega M,
    7. et al
    . Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 2006;174(11):1249–1256.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Busing KL,
    2. Thursky KA,
    3. Black JF,
    4. MacGregor L,
    5. Street AC,
    6. Kennedy MP,
    7. Brown GV
    . Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool. Emerg Med Australas 2007;19(5):418–426.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Menéndez R,
    2. Torres A,
    3. Zalacaín R,
    4. Aspa J,
    5. Martín-Villasclaras JJ,
    6. Borderías L,
    7. et al
    ; Neumofail Group. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004;59(11):960–965.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Bruns AH,
    2. Oosterheert JJ,
    3. Prokop M,
    4. Lammers JW,
    5. Hak E,
    6. Hoepelman AI
    . Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia. Clin Infect Dis 2007;45(8):983–991.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Marrie TJ,
    2. Marrie MD,
    3. Huang JQ
    . Low-risk patients admitted with community-acquired pneumonia. Am J Med 2005;118(12):1357–1363.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Restrepo MI,
    2. Mortensen EM,
    3. Pugh JA,
    4. Anzueto A
    . COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 2006;28(2):346–351.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Rello J,
    2. Rodriguez A,
    3. Torres A,
    4. Roig J,
    5. Sole-Violan J,
    6. Garnacho-Montero J,
    7. et al
    . Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 2006;27(6):1210–1216.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Reyes S,
    2. Martinez R,
    3. Vallés JM,
    4. Cases E,
    5. Menendez R
    . Determinants of hospital costs in community-acquired pneumonia. Eur Respir J 2008;31(5):1061–1067.
    OpenUrlAbstract/FREE Full Text
  27. 27.
    1. Menéndez R,
    2. Cremades MJ,
    3. Martínez-Moragón E,
    4. Soler Reyes S,
    5. Perpiñá M
    . Duration of length of stay in pneumonia: influence of clinical factors and hospital type. Eur Respir J 2003;22(4):643–648.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Sankaran RT,
    2. Mattana J,
    3. Pollack S,
    4. Bhat P,
    5. Ahuja T,
    6. Patel A,
    7. Singhal PC
    . Laboratory abnormalities in patients with bacterial pneumonia. Chest 1997;111(3):595–600.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Charles PG,
    2. Wolfe R,
    3. Whitby M,
    4. Fine MJ,
    5. Fuller AJ,
    6. Stirling R,
    7. et al
    ; Australian Community-Acquired Pneumonia Study Collaboration. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia Clin Infect Dis 2008;47(3):375–384.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Hedlund JU,
    2. Hansson LO,
    3. Ortqvist AB
    . Hypoalbuminemia in hospitalized patients with community-acquired pneumonia. Arch Intern Med 1995;155(13):1438–1442.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Blot SI,
    2. Rodriguez A,
    3. Solé-Violán J,
    4. Blanquer J,
    5. Almirall J,
    6. Rello J
    ; Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators. Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia. Crit Care Med 2007;35(11):2509–2514.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords